We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

84 hedge funds and large institutions have $601M invested in PTC Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

29% more funds holding

Funds holding: 65 → 84 (+19)

0% more capital invested

Capital invested by funds: $600M → $601M (+$1.09M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
2.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
36
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SAM
Sectoral Asset Management
Quebec, Canada
+$12.9M
2
Millennium Management
Millennium Management
New York
+$9.57M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.13M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$5.1M
5
BFA
BlackRock Fund Advisors
California
+$4.9M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$25.7M
2
Jennison Associates
Jennison Associates
New York
-$22.5M
3
O
OrbiMed
New York
-$14M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$12.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
Pier Capital
Connecticut
$3.54M +$2.9M +135,445 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$3.34M +$598K +27,938 +28%
EI
28
EAM Investors
California
$2.86M +$2.34M +109,344 New
TCIM
29
TIAA CREF Investment Management
New York
$2.61M +$1.28M +59,768 +150%
USAA
30
United Services Automobile Association
Texas
$2.4M – – –
RFC
31
Russell Frank Company
Washington
$2.17M +$1.78M +83,192 New
PAMU
32
Pictet Asset Management (UK)
United Kingdom
$2.17M +$503K +23,500 +40%
Invesco
33
Invesco
Georgia
$2.08M +$43.3K +2,021 +3%
TCM
34
Tekla Capital Management
Massachusetts
$2.07M – – –
CCI
35
Columbus Circle Investors
$1.71M +$1.4M +65,304 New
BIM
36
BlackRock Investment Management
Delaware
$1.7M +$694K +32,439 +100%
Axa
37
Axa
France
$1.62M +$1.32M +61,810 New
Ameriprise
38
Ameriprise
Minnesota
$1.61M +$1.32M +61,757 New
Deutsche Bank
39
Deutsche Bank
Germany
$1.51M +$695K +32,462 +128%
Charles Schwab
40
Charles Schwab
California
$1.31M +$331K +15,474 +44%
RA
41
Royce & Associates
New York
$1.31M +$1.07M +50,000 New
BA
42
BlackRock Advisors
Delaware
$1.09M -$848K -39,616 -49%
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$1.09M +$895K +41,820 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$426K +19,900 +97%
ARC
45
Absolute Return Capital
Massachusetts
$839K +$687K +32,080 New
TA
46
Teachers Advisors
New York
$818K +$313K +14,628 +88%
AllianceBernstein
47
AllianceBernstein
Tennessee
$810K +$661K +30,888 +27,579%
ProShare Advisors
48
ProShare Advisors
Maryland
$760K -$105K -4,925 -14%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$635K +$520K +24,292 New
Renaissance Technologies
50
Renaissance Technologies
New York
$565K +$462K +21,600 New
1
2
3 4

PTCT Hedge Fund Activity: Q2 2014 in Review

84 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2014, worth a combined $601M — up 0.18% from $600M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PTCT positions and 8 closed out — a net gain of 19 holders — while 36 added to existing stakes and 12 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $12.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $25.7M sold.

  • 84 institutional investors held PTC Therapeutics (PTCT) as of Q2 2014, up from 65 in Q1 2014.
  • Funds reported $601M of PTC Therapeutics stock for Q2 2014, up 0.18% quarter-over-quarter.
  • 27 funds opened new PTC Therapeutics positions in Q2 2014 and 8 closed out, a net change of +19 holders.
  • The largest PTC Therapeutics buyer in Q2 2014 was Sectoral Asset Management, an estimated $12.9M added.
  • The largest PTC Therapeutics seller in Q2 2014 was RA Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2014.